Reforming the World Health Organization's Essential Medicines List: Essential but Unaffordable

JAMA. 2022 Nov 8;328(18):1807-1808. doi: 10.1001/jama.2022.19459.
No abstract available

Plain language summary

This Viewpoint proposes restructuring the WHO Essential Medicines List to remove consideration of cost and cost-effectiveness from the expert committee reviews of clinical effectiveness, safety, and public health value, and chartering a new framework for pooled global negotiation and procurement of costly medicines included in the list.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Drugs, Essential* / economics
  • Drugs, Essential* / standards
  • Global Health* / economics
  • Global Health* / standards
  • Health Care Reform* / economics
  • Health Care Reform* / standards
  • World Health Organization*


  • Drugs, Essential